Digital health and drug reference app markets projected to grow significantly

The global market for drug reference applications and digital health tools is experiencing significant expansion. The drug reference apps market, valued at USD 1.48 billion in 2025, is projected to reach USD 3.70 billion by 2034, growing at a compound annual growth rate of 10.92%. This growth is driven by rising disease prevalence, increasing healthcare expenditure, and advancements in precision medicine and artificial intelligence.

Simultaneously, the broader mHealth and digital health application market is expected to exceed USD 86 billion by 2030. This surge is fueled by increased health awareness, preventive medicine initiatives, and the adoption of connected bio-wearables. However, industry data highlights significant challenges in user retention, noting that up to 80% of users abandon mobile applications due to onboarding friction, which impacts the long-term profitability of health and wellness brands.